Setroreliks (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Setroreliks" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

4web.archive.org

1^st place

3nih.gov

4^th place

13^th place

2fda.gov

447^th place

792^nd place

2doi.org

2^nd place

4^th place

1tga.gov.au

3,984^th place

4,575^th place

1emdserono.com

low place

1springer.com

274^th place

596^th place

doi.org (Global: 2^nd place; Indonesian: 4^th place)

Lin YH, Wen YR, Chang Y, Seow KM, Hsieh BC, Hwang JL, Tzeng CR (June 2010). "Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study". Fertility and Sterility. 94 (1): 179–83. doi:10.1016/j.fertnstert.2009.02.062. PMID 19339001.
Tata B, Mimouni NE, Barbotin AL, Malone SA, Loyens A, Pigny P, et al. (June 2018). "Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood". Nature Medicine. 24 (6): 834–846. doi:10.1038/s41591-018-0035-5. PMC 6098696. PMID 29760445.

emdserono.com (Global: low place; Indonesian: low place)

"Cetrotide 0.25 mg" (PDF). emdserono.com. Diarsipkan dari asli (PDF) tanggal 5 April 2016. Diakses tanggal 30 January 2016.

fda.gov (Global: 447^th place; Indonesian: 792^nd place)

"2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Diarsipkan dari versi aslinya tanggal 30 June 2023. Diakses tanggal 30 June 2023.
"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Diarsipkan dari versi aslinya tanggal 29 June 2023. Diakses tanggal 29 June 2023.

nih.gov (Global: 4^th place; Indonesian: 13^th place)

pubmed.ncbi.nlm.nih.gov

Lin YH, Wen YR, Chang Y, Seow KM, Hsieh BC, Hwang JL, Tzeng CR (June 2010). "Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study". Fertility and Sterility. 94 (1): 179–83. doi:10.1016/j.fertnstert.2009.02.062. PMID 19339001.
Tata B, Mimouni NE, Barbotin AL, Malone SA, Loyens A, Pigny P, et al. (June 2018). "Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood". Nature Medicine. 24 (6): 834–846. doi:10.1038/s41591-018-0035-5. PMC 6098696. PMID 29760445.

ncbi.nlm.nih.gov

Tata B, Mimouni NE, Barbotin AL, Malone SA, Loyens A, Pigny P, et al. (June 2018). "Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood". Nature Medicine. 24 (6): 834–846. doi:10.1038/s41591-018-0035-5. PMC 6098696. PMID 29760445.

springer.com (Global: 274^th place; Indonesian: 596^th place)

adisinsight.springer.com

"Cetrorelix". AdisInsight.

tga.gov.au (Global: 3,984^th place; Indonesian: 4,575^th place)

"Cetrorelix RBX (Sun Pharma ANZ Pty Ltd)". Therapeutic Goods Administration (TGA). 13 March 2025. Diakses tanggal 24 March 2025.

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

"Cetrotide 0.25 mg" (PDF). emdserono.com. Diarsipkan dari asli (PDF) tanggal 5 April 2016. Diakses tanggal 30 January 2016.
"2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Diarsipkan dari versi aslinya tanggal 30 June 2023. Diakses tanggal 30 June 2023.
"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Diarsipkan dari versi aslinya tanggal 29 June 2023. Diakses tanggal 29 June 2023.
Aeternia Zentaris product page

Setroreliks (Indonesian Wikipedia)

doi.org (Global: 2nd place; Indonesian: 4th place)

emdserono.com (Global: low place; Indonesian: low place)

fda.gov (Global: 447th place; Indonesian: 792nd place)

nih.gov (Global: 4th place; Indonesian: 13th place)